Successful Treatment of Angioimmunoblastic Lymphadenopathy (AIL) and B Cell Prolymphocytic Leukemia (B-PLL) with Interferon-α

  • P. Trinkler
  • D. Mustroph
  • H. Hagenah
  • H. Mönch
  • H. W. v. Heyden
Conference paper

Abstract

Angioimmunoblastic lymphadenopathy (AIL), first described by Frizzera in 1974 [1], and B cell prolymphocytic leukemia (B-PLL), first described by Galton in 1963 [2], are two rare low-grade malignant non-Hodgkin lymphomas. An effective standard therapy does not exist for either disease. Chemotherapy is usually of no durable effect in both disorders. In B-PLL, splenectomy and leukaphersis can be useful [3, 4].

Keywords

Lymphoma Leukemia Sedimentation Electrophoresis Anemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Frizzera G, Moran EM, Rappaport H (1974) Angioimmunoblastic lymphadenopathy with dysproteinuria. Lancet I:1070–1073PubMedCrossRefGoogle Scholar
  2. 2.
    Galton DAG, Wiltshaw E, Boesen E et al. (1963) Prolymphocytic leukemia. British Empire Cancer Campaign for Research 41st Annual Report, p 55Google Scholar
  3. 3.
    Galton DAG, Goldman JM, Wiltshaw E et al. (1974) Prolymphocytic leukemia. Br J Haematol 27:7–23PubMedCrossRefGoogle Scholar
  4. 4.
    Buskard NA, Catovsky D, Okos A et al. (1976) Prolymphocytic leukemia:cell studies and treatment with leucapheresis. Hamatol Bluttransfus 18:237–253PubMedGoogle Scholar
  5. 5.
    Feremens WW, Khodadadi E (1987) Alpha-interferon-therapy in refractory angioimmunoblastic lymphadenopathy. Eur J Haematol 39:91CrossRefGoogle Scholar
  6. 6.
    Jacobs P, Le Roux I, Wood L, Bolding E (1987) Interferon response in B-cell prolymphocytic leukemia. Br J Haematol 65:375–376PubMedCrossRefGoogle Scholar
  7. 7.
    Delannoy A, Balligand JC, Cedant T (1987) Interferon and B-cell prolymphocytic leukemia. Br J Haematol 66:579–580PubMedCrossRefGoogle Scholar
  8. 8.
    Thiel E, Schlag R, Hill W et al. (1987) B-CLL in early phase responds to recombinant alpha-2b interferon therapy as determined in a pilot study. Blut 55:205–412 A74CrossRefGoogle Scholar
  9. 9.
    Ouesada JR, Reuben J, Manning JT et al. (1984) Alpha interferon for induction of remission in hairy-cell-leukemia, N Engl J Med 310:15–18CrossRefGoogle Scholar
  10. 10.
    Catovsky E, O’Brien M, Melo JK et al. (1984) Hairy cell leukemia (HCL) variant:an intermediate disease between HCL and B prolymphocytic leukemia. Semin Oncol 11:362PubMedGoogle Scholar
  11. 11.
    Foon KA, Schroff RW, Gale RP (1982) Surface markers on leukemia and lymphoma cells:recent advances. Blood 60:1–19PubMedGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1990

Authors and Affiliations

  • P. Trinkler
  • D. Mustroph
  • H. Hagenah
  • H. Mönch
  • H. W. v. Heyden

There are no affiliations available

Personalised recommendations